Send to

Choose Destination
Immunogenetics. 1997;46(1):29-34.

Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice.

Author information

Department of Microbiology, Stanford University Medical Center, California 94305, USA.


The autoantigen glutamic acid decarboxylase 65 (GAD 65) is believed to be an important target antigen in insulin-dependent diabetes mellitus (IDDM), since an age-related spontaneous breakdown in tolerance is observed, and cell-mediated and autoantibody immune responses have been reported in humans and NOD mice. We sought to identify immunogenic epitopes of GAD 65 which are presented to T cells by the type I diabetes susceptibility allele (Ag7), using overlapping 15-mer synthetic peptides spanning the entire sequence of this protein. Four epitopes (p206 - 220, p221 - 235, p286 - 300, p571 - 585) were identified by screening a panel of T-cell hybridomas generated from GAD 65-immunized NOD mice. These immunogenic epitopes are unrelated to the previously described T-cell epitopes of GAD 65 reported in NOD mice. Of the GAD 65 amino acid sequence, 206 - 220 and 221 - 235 are the two most dominant T-cell epitopes identified in this study. Sixty-three percent and 25% of GAD 65-responding T cell hybridomas react to p206 - 220 and p221 - 235, respectively. The remaining two peptides (p286 - 300, p571 - 585) are less dominant T-cell responses. The identification of the whole spectrum of GAD 65 Ag7 epitopes should further the investigation of the role of this autoantigen in the pathogenesis of IDDM.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center